CDSCO UID IMP/MD/2019/000511_0f0e5f038f5f9be051a98a006bceff3e_28fa7791177f692a0aeb9bd55275ec17
Coronary Stent System
Abbott Healthcare Private Limited·Device Class Class D·India CDSCO·Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Registration details
- UID
- IMP/MD/2019/000511_0f0e5f038f5f9be051a98a006bceff3e_28fa7791177f692a0aeb9bd55275ec17
- Device class
- Class D
- Brand name
- Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
- License holder
- Abbott Healthcare Private Limited
- Approving authority
- CDSCO
- Product information
- Multi-Link 8, Multi-Link 8 SV, and Multi-Link 8 LL Coronary Stent Systems are indicated for improving coronary luminal diameter in the following: Multi-Link 8: Patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System) with reference vessel diameters from 2.5 mm to 4.0 mm. Restoring coronary flow in patients experiencing acute myocardial infarction, who within 12 hours of symptom onset present with native coronary artery lesions (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System) with reference vessel diameters from 2.5 mm to 4.0 mm. Patients with symptomatic ischemic heart disease due to lesions in saphenous vein bypass grafts (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System) with reference vessel diameters from 3.0 mm to 4.0 mm. Multi-Link 8 SV: Patients with abrupt or threatened abrupt closure with failed interventional therapy of de novo and restenotic native coronary artery lesions (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System) with reference vessel diameters from 2.0 mm to 2.5 mm. Patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System) with reference vessel diameters from 2.25 mm to 2.5 mm. Multi-Link 8 LL: Patients with symptomatic ischemic heart disease due to discrete de novo native coronary artery lesions (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System) with reference vessel diameters from 2.5 mm to 4.0 mm. Restoring coronary flow in patients experiencing acute myocardial infarction, who within 12 hours of symptom onset present with native coronary artery lesions (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System) with reference vessel diameters from 2.5 mm to 4.0 mm. Patients with symptomatic ischemic heart disease due to lesions in saphenous vein bypass grafts (Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System) with reference vessel diameters from 3.0 mm to 4.0 mm
Similar products (9)
Other products with the same name or brand
Coronary Stent System
Brand: Pantera
Biotronik Medical Devices India Pvt Ltd.
Class D
Coronary Stent System
Brand: Yukon Choice 4
Translumina Therapeutics LLP
Class D
Coronary Stent System
Brand: Yukon Choice 4
Translumina Therapeutics LLP
Class D
Coronary Stent Graft System
Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Abbott Healthcare Private Limited
Class D
Coronary Stent System
Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Abbott Healthcare Private Limited
Class D
Drug Eluting Stent
Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Abbott Healthcare Private Limited
Class D
Drug Eluting Stent
Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Abbott Healthcare Private Limited
Class D
Drug Eluting Stent
Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Abbott Healthcare Private Limited
Class D
Drug Eluting Stent
Brand: Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System
Abbott Healthcare Private Limited
Class D
Other products from Abbott Healthcare Private Limited
Products from the same license holder (10 products)
LibreView software which includes LibreLinkUp mobile application
Class B
FreeStyle LibreLink app
Class B
Flash Glucose Monitoring System
Brand: FreeStyle Libre Pro
Class C
Flash Glucose Monitoring System
Brand: FreeStyle Libre Pro
Class C
CORONARY DILATATION CATHETER
Brand: NC TREK NEO™
Class C
Suture-Mediated Closure System
Brand: NC TREK NEO™
Class C
CORONARY DILATATION CATHETER
Brand: NC TREK NEO™
Class C
Drug Eluting Stents
Brand: Xience Alpine™ Everolimus Eluting Coronary Stent System
Class D
Drug Eluting Stents
Brand: Xience Alpine™ Everolimus Eluting Coronary Stent System
Class D
Drug Eluting Stents
Brand: Xience Alpine™ Everolimus Eluting Coronary Stent System
Class D
About this record
Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000511_0f0e5f038f5f9be051a98a006bceff3e_28fa7791177f692a0aeb9bd55275ec17. This device is marketed under the brand name Xience Prime , Xience Prime SV and Xience Prime LL Everolimus Eluting Coronary Stent System. The license holder is Abbott Healthcare Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.